TTK Healthcare has accepted the resignation of M/s Aiyar & Co. as its tax auditor, effective August 26, 2026. The firm cited regulatory ineligibility under Institute of Chartered Accountants of India (ICAI) guidelines as the reason for stepping down from the FY25-26 assignment.

The resignation stems from a review of the firm’s Peer Review Certificate issued by the ICAI Peer Review Board. M/s Aiyar & Co. stated that current guidelines restrict their scope, rendering them ineligible to sign audit reports for listed companies. Continuing with the tax audit would violate professional and regulatory standards set by the ICAI.

Regulatory Disclosure

TTK Healthcare disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, read with Schedule III of the Listing Regulations.

Next Steps

The Audit Committee and the Board of Directors will initiate action to appoint a new tax auditor for the Financial Year 2025-26. The company noted that the previous acceptance of the assignment was made in good faith before the regulatory scope was clarified.

Gowry A Jaishankar, DGM - Legal & Company Secretary, signed the disclosure letter sent to the BSE and NSE on August 27, 2026.

TTK Healthcare reported a significant improvement in its standalone financial performance for Q1, with net profit rising to 213M rupees compared to 130M rupees in the corresponding quarter of the previous year. Revenue for the quarter also grew on a year-on-year basis, climbing to 2.6B rupees from 2.3B rupees, reflecting healthy top-line momentum across the business.

Profitability and Margin Expansion

The company's operational performance stood out during the quarter, with EBITDA registering a sharp increase. The following table summarizes the key financial metrics for the quarter:

EBITDA surged to 147M rupees from 27M rupees in the year-ago quarter, representing a substantial year-on-year improvement in operating earnings. The EBITDA margin expanded markedly to 5.7% from 1.2% in the same period last year, underscoring a meaningful enhancement in operational efficiency.

Key Financial Highlights

The quarterly results reflect the following notable developments:

• Net profit grew from 130M rupees to 213M rupees on a year-on-year basis
• Revenue increased from 2.3B rupees to 2.6B rupees YoY
• EBITDA rose sharply from 27M rupees to 147M rupees YoY
• EBITDA margin expanded by 450 basis points, moving from 1.2% to 5.7% YoY

The combination of revenue growth and a significant improvement in EBITDA margin indicates that TTK Healthcare achieved stronger cost management and operating leverage during the quarter compared to the year-ago period.